Torsten Derr to head Lanxess subsidiary Saltigo Torsten Derr to head Lanxess subsidiary Saltigo Takes over from Wolfgang Schmidt, who is retiring, on 1 April 2016 Patheon appoints Global Business Controller Patheon appoints Global Business Controller Andrew Long will build the firm's financial planning and performance management tools and processes Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry He takes up the position on 1 March and Acting CEO Alison Clough will step down Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance Wood holds more than 20 years of regulatory affairs experience focusing on drugs for diseases with high unmet need Sygnature Discovery makes two key appointments as expansion continues Sygnature Discovery makes two key appointments as expansion continues Also expands its team of scientists by adding six people to the team Recipharm names 2015 International Environmental Award winner Recipharm names 2015 International Environmental Award winner Jerker Fick takes the award for his research into the effect pharmaceuticals have on the environment Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer Cao is a top researcher at the University of Southern Florida in Tampa Avita makes three key board appointments Avita makes three key board appointments Three are based in the US and three in Australia Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee Former CEO of the Clinical Products Division at Siemens Healthcare joins the firm on 1 April Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics Brings operating expertise to development-stage company focused on developing therapies for diseases caused by poor blood flow Astellas names James Robinson as President, Americas Operations Astellas names James Robinson as President, Americas Operations He takes up the role on 1 April, succeeding Masao Yoshida, who retires in June Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development Also joins the Executive Committee at the French drugmaker New VP of Development and Analytical Services at Catalent New VP of Development and Analytical Services at Catalent Sally Langa joins the US drug delivery technology specialist David Budd to join Epistem as Chief Executive David Budd to join Epistem as Chief Executive He will start his new role by the middle of April CytRx appoints Olivia Ware as Chief Commercial Officer CytRx appoints Olivia Ware as Chief Commercial Officer Los Angeles-based firm specialises in oncology and is preparing for the results of a pivotal Phase III trial Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals He previously held managerial and business development roles at Teva Pharmaceuticals and Dexcel Pharma Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs He joins the firm with more than 15 years of vaccine research and development experience and leadership roles AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business Dawn Von Rohr joins AMRI from Mallinckrodt Pharmaceuticals where she was VP and General Manager, Global APIs Paolo Paoletti joins PsiOxus Therapeutics at Chairman Paolo Paoletti joins PsiOxus Therapeutics at Chairman Former President of GSK Oncology adds depth of knowledge of cancer R&D Merck announces new biopharma heads for North America and China Merck announces new biopharma heads for North America and China Gary Zieziula and Marc Horn to head biopharma business in North America and China, respectively Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Will build sales in the Boston Biotech community Avacta hires Philippe Cotrel as Chief Commercial Officer Avacta hires Philippe Cotrel as Chief Commercial Officer Joins the UK firm from Abcam Averica Discovery appoints Cynthia Berger as Vice President of Operations Averica Discovery appoints Cynthia Berger as Vice President of Operations Will contribute broadly to the firm's growth and development Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult The new Medicines Technologies Catapult at Alderley Park, Cheshire, UK, will support industry in developing new technologies primarily for the preclinical evaluation of medicines